United States · FDA National Drug Code directory

Travoprost Ophthalmic

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2432_8a987f3e-548d-4895-8620-312005b2e3b3
Product NDC
72162-2432
Form
SOLUTION
Composition / generic term
Travoprost Ophthalmic Solution
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20210415
Source listing expiry
20271231

Source-listed ingredients

  • TRAVOPROST — .04 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (72162-2432-2) / 2.5 mL in 1 BOTTLE · 72162-2432-2
  • 1 BOTTLE in 1 CARTON (72162-2432-4) / 5 mL in 1 BOTTLE · 72162-2432-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Travoprost Ophthalmic — United States | Molindra Medicines